Regulation 46B Labelling of certain POC investigational medicinal productsF1
Regulation 46 does not apply to a POC investigational medicinal product that is to be administered in its entirety immediately after manufacture.
Annotations
Textual amendments
- F1
Pt. 7 substituted (28.4.2026) by The Medicines for Human Use (Clinical Trials) (Amendment) Regulations 2025 (S.I. 2025/538), regs. 1(2), 32